Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity [NA]
This completed clinical trial validates algorithms for reducing basal insulin infusion rates during physical activity in people with Type 1 …
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: Alteration of Myocardial Deformations in Diabetes: Relationship to Micro-angiopathy [NA]
A completed clinical trial examined how Type 1 diabetes affects myocardial deformation and its relationship to microangiopathy.
-
CLINICAL_TRIALS trial_result · 2013-04-16Clinical Trial Update: Performance Study to Test the GlucoMen®Day System Using Intravascular and Subcutaneous Microdialysis in Subjects With Type 1 Diabetes
Completed clinical trial evaluating the GlucoMen Day System for glucose monitoring using intravascular and subcutaneous microdialysis in adu…
-
CLINICAL_TRIALS trial_result · 2013-04-16Clinical Trial Update: Islet Transplantation for Type 1 Diabetes Mellitus [Phase 1, Phase 2]
A Phase 1/2 clinical trial of islet transplantation for Type 1 Diabetes Mellitus has been terminated, with results posted in 2013.
-
CLINICAL_TRIALS withdrawal · 2013-04-12Clinical Trial Update: Non-enhanced Magnetic Resonance Angiography of Diabetic Ischemic Lower Limbs
A clinical trial evaluating non-enhanced magnetic resonance angiography for ischemic lower limbs in individuals with type 1 diabetes has bee…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-04-10FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Cord Blood Plus Vitamin D and Omega 3s in T1D [Phase 1]
A Phase 1 clinical trial evaluating cord blood plus vitamin D and omega-3s in Type 1 diabetes; the study has completed.
-
CLINICAL_TRIALS research · 2013-04-04Clinical Trial Update: Closing the Loop in Young Children With Type 1 Diabetes [Phase 2]
Phase 2 clinical trial update on Type 1 Diabetes in young children; the current status is not specified.
-
CLINICAL_TRIALS research · 2013-04-02Clinical Trial Update: A Comparison Between Pupillometry, Heart Rate Variability and Metaiodobenzylguanidine Scintigraphy for the Diagnosis of Early Diabetic Autonomic Neuropathy in Type 1 Diabetes
This clinical trial update describes a study comparing pupillometry, heart rate variability, and metaiodobenzylguanidine scintigraphy for di…
-
FDA approval · 2013-03-28FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro submitted by Eli Lilly and Company.
-
FDA approval · 2013-03-28FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly and Company. The action concerns the su…
-
FDA approval · 2013-03-27FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine), a pen formulation, filed by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes [Phase 1, Phase 2]
Terminated Phase 1/2 trial evaluating islet transplantation for Type 1 diabetes using efalizumab (Raptiva) and sirolimus; results were poste…
-
CLINICAL_TRIALS trial_result · 2013-03-20Clinical Trial Update: Treatment Use of Generex Oral-lyn™ in Patients With Diabetes
Clinical trial NCT00948493 evaluating Generex Oral-lyn for diabetes is no longer available.
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: Bone Health in Type 1 Diabetes
A completed clinical trial evaluating bone health in people with type 1 diabetes and osteoporosis. The document does not specify results.
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Pharmacokinetic and Injection Site Toleration of BIOD-238 and BIOD-250 Compared to Humalog® in Subjects With Type 1 Diabetes [Phase 1]
Phase 1 trial update reporting pharmacokinetic profiles and injection site toleration of BIOD-238 and BIOD-250 compared with Humalog (insuli…
-
FDA approval · 2013-03-14FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly and Company. The notice indicates a supplemental approval rela…
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: Testing the Effect of the InsuPad Device in Daily Life Conditions [NA]
The clinical trial evaluating the InsuPad device in daily life conditions for adults with Type 1 diabetes mellitus and Type 2 diabetes melli…
-
FDA approval · 2013-03-11FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMALOG MIX75/25, a premixed insulin lispro product manufactured by Eli Lilly and Company.
-
FDA approval · 2013-03-11FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2013-03-11FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro (Humalog) submitted by Eli Lilly and Company. The approval confirms the supplemen…
-
FDA approval · 2013-03-09FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
The FDA approved a supplemental application for the insulin aspart protamine and insulin aspart mix 70/30 product, confirming continued regu…
-
FDA approval · 2013-03-09FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approves NovoLog (insulin aspart) supplemental application submitted by Novo Nordisk. The approval updates the labeling and/or indicatio…
-
FDA label_change · 2013-03-09FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a Novo Nordisk supplemental application for LEVEMIR (insulin detemir), updating the product labeling.
-
FDA approval · 2013-03-09FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN 70/30 (insulin human) from Eli Lilly and Company.